Practice Expertise

  • Health & Life Sciences
  • Pharmacy
  • Health Care Transactions
  • Wholesale Drug and Device Distribution

Areas of Practice

  • Health & Life Sciences
  • Health Care Transactions
  • Pharmacy
  • Wholesale Drug and Device Distribution
  • Health & Life Sciences
  • Pharmacy, Drug and Device
  • View More

Profile

Collaborative and exacting health care regulatory and licensing counsel

Anne O'Brien helps health care providers and entities navigate the web of regulations governing their current operations and new business initiatives. With clients including pharmacies, wholesale distributors, manufacturers, 3PLs, 503B outsourcing facilities, DMEPOS suppliers, hospitals, clinics, long-term care facilities, behavioral health providers, pharmacists and other individual practitioners, Anne advises on:

  • Regulatory compliance
  • Licensure requirements
  • New business models and related initiatives

Having cultivated healthy working relationships with regulators throughout the country and bringing a meticulous approach to managing the myriad regulatory obligations facing her clients, Anne delivers compliance strategies that are practical and effective. Clients appreciate Anne's collaborative style, in which she develops a deep familiarity with their business needs to inform the legal counsel she provides.

Anne is national chair of the Licensing sub-group of the firm’s Health & Life Sciences Practice Group.

Bar Admissions

  • Illinois

Education

  • University of Illinois Urbana-Champaign (B.S., 1988)
    • Microbiology
  • Northwestern University, Kellogg School of Management, Certificate, Quarles & Brady Leadership Program (2018)
  • University of New Hampshire Franklin Pierce School of Law (J.D., 1991)

Areas of Practice

  • Health & Life Sciences
  • Health Care Transactions
  • Pharmacy
  • Wholesale Drug and Device Distribution
  • Health & Life Sciences
  • Pharmacy, Drug and Device

Professional Career



Articles

  • "DEA Compliance in a New Era"
  • "Hot Topics in Pharmacy Law"
  • "Illinois Pharmacy Law Update"
  • "Industry/Business of Pharmacy"
  • "New Technology"
  • "Physician Extender Collaboration & Supervision"
  • "Texas Abortion Bills S.B. 4 and S.B. 8"
  • "Trends in State Licensing and Medicare & Medicaid Enrollment"
  • "Trends in the Regulation of Automation"
  • "Trends in the Regulation of Automation"
  • "Walking (With All Due Care) in a Winter Wonderland"
  • 2018 Farm Bill, Technician Ratios, and Hazardous Waste Rules: Hot Topics in Pharmacy Law
  • Doing a Health Care Transaction in Illinois? Be Prepared to Tell the Attorney General
  • Illinois Braces for the End of the PHE
  • Illinois Increases Lead Time for Change of Ownership of In-State Pharmacies to 90 Days, Expands Circumstances Requiring Application 
  • Illinois Pharmacy Law Update
  • Illinois Pharmacy Law Update
  • Wait, What? Palmetto GBA and Novitas Solutions Now Administer Medicare DMEPOS
  • “Pharmacy Promotional Activities, Their Impact and Their Future: Coupons, Gift Cards, Reward Programs and Inducements"
  • “The Compliance and Innovation Balancing Act in Pharma and Biotech”

Seminar

  • 2018 Pharmacy Law Symposium
  • 2019 Pharmacy Law Symposium
  • 2022 Pharmacy Law Symposium
  • 2024 Pharmacy Law Symposium
  • Women in Leadership in Pharmacy Law

Meet our Firms and Professionals

WSG’s member firms include legal, investment banking and accounting experts across industries and on a global scale. We invite you to meet our member firms and professionals.